Andreas Henning
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
-
- Inhalation and Respiratory Drug Delivery
- Cystic Fibrosis Research Advances
Papers in
-
- Advanced Drug Delivery Systems 3
- Advancements in Transdermal Drug Delivery 3
-
- Inhalation and Respiratory Drug Delivery 5
- Cystic Fibrosis Research Advances 2
- Co-authors
- Claus‐Michael Lehr (6 shared papers)Marc Schneider (4 shared papers)Justin Hanes (2 shared papers)Craig S. Schneider (2 shared papers)Laura M. Ensign (2 shared papers)Ulrich F. Schaefer (3 shared papers)Dirk Neumann (3 shared papers)Stephanie Hein (2 shared papers)
- Journals
- European Journal of Pharmaceutics and Biopharmaceutics (2 papers)AAPS PharmSciTech (1 paper)Inhalation Toxicology (1 paper)Molecular Pharmaceutics (1 paper)Journal of Aerosol Medicine and Pulmonary Drug Delivery (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Andreas Henning
9 papers receiving 658 citations
Peers
Comparison fields: 5 of 90
- Pharmaceutical Science 360
- Pulmonary and Respiratory Medicine 253
- Dermatology 66
- Biomaterials 76
- Microbiology 24
Countries citing papers authored by Andreas Henning
This map shows the geographic impact of Andreas Henning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Henning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Henning more than expected).
Fields of papers citing papers by Andreas Henning
This network shows the impact of papers produced by Andreas Henning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Henning. The network helps show where Andreas Henning may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Henning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 258 | |
| 2 | 2013 | 91 | |
| 3 | 2007 | 85 | |
| 4 | 2010 | 83 | |
| 5 | 2009 | 53 | |
| 6 | 2008 | 33 | |
| 7 | 2009 | 26 | |
| 8 | 2008 | 23 | |
| 9 | 2008 | 20 |
About Andreas Henning
Andreas Henning is a scholar working on Pharmaceutical Science, Pulmonary and Respiratory Medicine, Dermatology, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 9 papers that have together received 672 indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (5 papers), Advanced Drug Delivery Systems (3 papers), Advancements in Transdermal Drug Delivery (3 papers), Contact Dermatitis and Allergies (2 papers), Cystic Fibrosis Research Advances (2 papers), Dermatology and Skin Diseases (2 papers), Allergic Rhinitis and Sensitization (1 paper) and Dysphagia Assessment and Management (1 paper). The work is most often cited by research in Pharmaceutical Science (360 citations), Pulmonary and Respiratory Medicine (253 citations), Dermatology (66 citations), Biomaterials (76 citations) and Microbiology (24 citations). Andreas Henning has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Claus‐Michael Lehr, Marc Schneider, Justin Hanes, Craig S. Schneider, Laura M. Ensign, Ulrich F. Schaefer, Dirk Neumann, Stephanie Hein, Michael Bur and Tao Yu. Their work appears in journals such as European Journal of Pharmaceutics and Biopharmaceutics, AAPS PharmSciTech, Inhalation Toxicology, Molecular Pharmaceutics and Journal of Aerosol Medicine and Pulmonary Drug Delivery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.